The most comprehensive handbook of its kind, AIDH provides up-to-date information on injectable medicines that will be useful in your daily practice.
The 6th edition contains more than 440 injectable medicines, ALL entries fully revised, including 24 new monographs.
Each monograph includes availability, generic/trade names, preparation, administration, stability, compatibility/incompatibility data, special notes. It also contains paediatric-specific information in many monographs.
The AIDH has a tough durable cover and enhanced spiral binding.
Watch this short video tutorial to find out how to use AIDH6
Updates - AIDH 6th Edition
Important updated information or errata that are identified in the AIDH 6th Edition will be noted here.
The adenosine monograph on page 20 has been amended to change information in the IV use for infants and children section. The dilution volume should read 1-2 mL. This amendment applies to books delivered before 13 November 2014. Amended ADENOSINE monograph
The flucloxacillin monograph on page 163 has been amended to change information in the IV use for infants and children section. Doses greater than 25 mg/kg are recommended to be infused to avoid phlebitis. In the IV administration section, a statement has been added to recommend that a central line be used for continuous infusions. This amendment applies to books delivered before 13 November 2014. Amended FLUCLOXACILLIN monograph
The ranitidine monograph on page 351 has been amended to change some information in the IV injection and IV infusions section. The reference to the ampoule containing 50 mg (2 mL) has been removed as some ampoules contain 50 mg/5 mL. This amendment will be made to the third reprint revised so applies to all copies received before June 2015. Amended RANITIDINE HYDROCHLORIDE monograph
The cytarabine monograph on page 454 has been amended to change some information in the special notes section. The reference to the high doses of cytarabine as being over 200 mg/m2 is outdated and has been removed. This amendment will be made to the third reprint revised so applies to all copies received before June 2015.
Accessing the Australian Injectable Drugs Handbook on your smart phone or tablet
Did you know that if your hospital or university has an HCN (Health Communications Network) subscription and you can use the hospital or university’s wi-fi on your device, you can access the Australian Injectable Drugs Handbook? You can access information on more than 400 injectable drugs in the palm of your hand—on the ward, at the patient’s bedside, out visiting a patient, or anywhere! Open your browser and go to aidh.hcn.com.au.
For further enquiries about online subscriptions should be directed to email@example.com.
Updates - AIDH 5th Edition
Important updated information or errata that are identified in the AIDH 5th Edition will be noted here. New monographs are listed here.
The calcium gluconate monograph on page 76 has been amended to change some information in the special notes section. The reference to the ampoule containing 10% elemental calcium is incorrect and has been removed. This amendment will be made to the third reprint revised so applies to all copies received before July 2012. Amended calcium gluconate monograph
The iron polymaltose complex monograph on page 240 has been updated to reflect current practice. This amendment will be made to the third reprint revised so applies to all copies received before August 2012. Amended iron polymaltose complex monograph
The piperacillin sodium with tazobactam sodium monograph on page 338 has been amended to change some information in the special notes section. The sodium content for Other brands should read 2.35 mmol (54 mg). This amendment will be made to the third reprint revised so applies to copies received before July 2012. Amended piperacillin-tazobactam monograph
The mycophenolate mofetil monograph on page 293 has been amended to modify the ‘Caution’ in the SPECIAL NOTES. The caution regarding teratogenicity has been changed to recommend precautions for handling but not the need to handle as a cytotoxic. This amendment was made to the first reprint revised and to some copies of the original print run received before September 2011. Amended mycophenolate mofetil monograph
New monographs - AIDH 5th edition
These extra monographs for five new drugs are only available in the online version of AIDH and here. They will be available in print in the 6th edition.
Updates for the AIDH 4th edition are no longer available; this edition is out of date.
Feedback from users
SHPA welcomes feedback from those who use the AIDH - nurses, pharmacists and others, about improvements in content and/or readability. Send your feedback to firstname.lastname@example.org.
Volunteer to review for the next edition of the AIDH
An essential part of the AIDH is that each monograph is read by nurses and pharmacists from different practice settings to ensure that information is conveyed clearly to avoid confusion. Reviewers are acknowledged with thanks in the introductory pages of the AIDH. Participating in a review of the AIDH may contribute to Continuing Professional Development (CPD) points. If you are willing to be involved in future monograph reviews, please email your contact details, level of experience and areas of interest to email@example.com.